Does hyperpolarized MR using [1-13C]pyruvate provide a method for the assessment of innate immune cell-driven inflammation in the heart after MI?
Hyperpolarized MR with [1-13C]pyruvate represents a novel, noninvasive imaging modality for assessing cardiac inflammation post-MI with potential for clinical translation.
Hyperpolarized MR using 1-13Cpyruvate provides a novel method for the assessment of innate immune cell-driven inflammation in the heart after MI, with broad potential applicability across other cardiovascular disease states and suitability for early clinical translation.
Lewis et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: